Facebook Linkedin Twitter

Phase III clinical trials (Drug development)

Antibodies responding to covid-19 coronavirus, illustration
Coronavirus

COVID-19 Returns in 20% of Patients Treated with Paxlovid

Chris Anderson -
0
Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer
News & Features

New Xtandi Results Very Promising in Recurrent Prostate Cancer

Malorye Branca -
0
Nutritionist calculating body mass index of woman for obesity treatment in a clinic room.
News & Features

Mounjaro Leads to Average 60lb Weight Loss in Latest Trial

Malorye Branca -
0
Middle Eastern appearance male oncologist talking to an older Black Female Patient about Claudin18.2 related CAR T cell and cancer vaccine therapies.
News & Features

OSE Immunotherapeutics Unveils Promising Phase III Cancer Vaccine Results

Alisa Kirkin -
0
Image of a heart with a DNA double helix in front of it to indicate genetic heart diseases such as transthyretin amyloid cardiomyopathy.
News & Features

BridgeBio’s Rare Cardiomyopathy Candidate Succeeds at Phase III

Helen Albert -
0
Lung cancer, illustration
News & Features

AZ’s Antibody Drug Conjugate Candidate Meets PFS Endpoint in NSCLC Phase III Trial

Chris Anderson -
0
Prostate cancer cells
News & Features

FDA Approves First-Line Enzalutamide/Talazoparib Combo in Prostate Cancer

Anita Chakraverty -
0
Motor neuron connecting to muscle fiber to illustrate myasthenia gravis
News & Features

FDA Approves TG Tx’s BRIUMVI for Relapsing Multiple Sclerosis

Malorye Branca -
0
Blood vessel with platelets, white blood cells and red blood cells.
News & Features

In Another Hemophilia Advance, Pfizer Reports Positive Results for Gene Therapy

Malorye Branca -
0
Body with gastric cancer tumor
News & Features

Astellas Zolbetuximab Trial Results Cement CLDN18.2 as Gastric-Cancer Biomarker  

Malorye Branca -
0
123...7Page 1 of 7

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine